{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T17:34:42Z","timestamp":1792949682536,"version":"4.5.0"},"reference-count":289,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.gene.2026.150438","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:55:50Z","timestamp":1791820550000},"page":"150438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The epigenetic landscape of hepatocellular carcinoma: from molecular mechanisms to early detection biomarkers and precision therapy"],"prefix":"10.1016","volume":"1016","author":[{"given":"Shraddha","family":"Dubey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2026.150438_b0005","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s11033-020-06089-9","article-title":"Romidepsin hepatocellular carcinoma suppression in mice is associated with deregulated gene expression of bone morphogenetic protein and Notch signaling pathway components","volume":"48","author":"Afaloniati","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.gene.2026.150438_b0015","doi-asserted-by":"crossref","first-page":"11975","DOI":"10.3390\/cimb46110711","article-title":"Dual Roles of microRNA-122 in hepatocellular carcinoma and breast cancer progression and metastasis: a comprehensive review","volume":"46","author":"Ageeli","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.gene.2026.150438_b0010","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s12253-019-00614-3","article-title":"MEG3: an oncogenic long non-coding rna in different cancers","volume":"25","author":"Al-Rugeebah","year":"2019","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.gene.2026.150438_b0020","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1200\/JCO.2022.40.4_suppl.574","article-title":"A phase Ib study of guadecitabine and durvalumab in patients with advanced hepatocellular carcinoma, pancreatic adenocarcinoma, and biliary cancers","volume":"40","author":"Algaze","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gene.2026.150438_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216374","article-title":"LINE-1 hypomethylation in human hepatocellular carcinomas correlates with shorter overall survival and CIMP phenotype","volume":"14","author":"Anwar","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2026.150438_b0030","doi-asserted-by":"crossref","first-page":"7894","DOI":"10.3748\/wjg.v20.i24.7894","article-title":"DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma","volume":"20","author":"Anwar","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.gene.2026.150438_b0035","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026534","article-title":"Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer","volume":"7","author":"Attar","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.gene.2026.150438_b0040","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1038\/sj.onc.1210608","article-title":"The MYST family of histone acetyltransferases and their intimate links to cancer","volume":"26","author":"Avvakumov","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2026.150438_b0045","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1093\/nar\/gkae233","article-title":"ARID1A regulates DNA repair through chromatin organization and its deficiency triggers DNA damage-mediated anti-tumor immune response","volume":"52","author":"Bakr, A., Della Corte, G., veselinov, O., Kelekci, S., Chen, m. m., lin, y. y., sigismondo, g., iacovone, m., cross, a., syed, r., jeong, y., sollier, e., liu, c. s., lutsik, p., krijgsveld, j., weichenhan, d., plass, c., popanda, o. and schmezer, P.","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.gene.2026.150438_b0050","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep.30168","article-title":"Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma","volume":"69","author":"Barcena-Varela","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.gene.2026.150438_b0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1042\/EBC20180061","article-title":"Acetylation & Co: an expanding repertoire of histone acylations regulates chromatin and transcription","volume":"63","author":"Barnes","year":"2019","journal-title":"Essays Biochem."},{"key":"10.1016\/j.gene.2026.150438_b0060","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1038\/s41467-021-23892-5","article-title":"Hakai is required for stabilization of core components of the m(6)A mRNA methylation machinery","volume":"12","author":"Bawankar","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2026.150438_b0065","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/1319-3767.37808","article-title":"Sorafenib in the treatment of advanced hepatocellular carcinoma","volume":"14","author":"Ben Mousa","year":"2008","journal-title":"Saudi J. Gastroenterol."},{"key":"10.1016\/j.gene.2026.150438_b0070","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.1002\/ctm2.352","article-title":"AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation","volume":"11","author":"Bian","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.gene.2026.150438_b0075","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2018.08.021","article-title":"Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy","volume":"837","author":"Biswas","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.gene.2026.150438_b0080","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.seminoncol.2011.08.001","article-title":"The role of microRNAs in human liver cancers","volume":"38","author":"Braconi","year":"2011","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.gene.2026.150438_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105801","article-title":"Histone modifications and non-coding RNAs: mutual epigenetic regulation and role in pathogenesis","volume":"23","author":"Bure","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2026.150438_b0090","first-page":"11","article-title":"The relevance of SOCS1 methylation and epigenetic therapy in diverse cell populations of hepatocellular carcinoma","volume":"Basel","author":"Cabral","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.gene.2026.150438_b0095","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1136\/gutjnl-2019-318882","article-title":"Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma","volume":"68","author":"Cai","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.gene.2026.150438_b0100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41420-021-00703-w","article-title":"RBM15 promotes hepatocellular carcinoma progression by regulating N6-methyladenosine modification of YES1 mRNA in an IGF2BP1-dependent manner","volume":"7","author":"Cai","year":"2021","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.gene.2026.150438_b0105","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1476-4598-9-108","article-title":"MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha\/HIF-1beta","volume":"9","author":"Cao","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.gene.2026.150438_b0110","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/gutjnl-2024-331903","article-title":"Targeting the oncogenic m6A demethylase FTO suppresses tumourigenesis and potentiates immune response in hepatocellular carcinoma","volume":"74","author":"Chen","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.gene.2026.150438_b0115","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1002\/hep.29683","article-title":"RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2","volume":"67","author":"Chen","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.gene.2026.150438_b0120","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/1878-0261.12593","article-title":"Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras\/Raf\/ERK pathways","volume":"14","author":"Chen","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.gene.2026.150438_b0125","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.canlet.2020.01.022","article-title":"Exosome-transmitted circular RNA hsa_circ_0051443 suppresses hepatocellular carcinoma progression","volume":"475","author":"Chen","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.gene.2026.150438_b0130","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.apsb.2019.09.006","article-title":"Epigenetic strategies synergize with PD-L1\/PD-1 targeted cancer immunotherapies to enhance antitumor responses","volume":"10","author":"Chen","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.gene.2026.150438_b0135","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1158\/0008-5472.CAN-21-1628","article-title":"Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma","volume":"82","author":"Chen","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2026.150438_b0140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12943-019-1053-8","article-title":"WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1","volume":"18","author":"Chen","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.gene.2026.150438_b0145","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/s41418-018-0220-6","article-title":"Circular RNA circAGO2 drives cancer progression through facilitating HuR-repressed functions of AGO2-miRNA complexes","volume":"26","author":"Chen","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.gene.2026.150438_b0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12943-020-01239-w","article-title":"ALKBH5 suppresses malignancy of hepatocellular carcinoma via m(6)A-guided epigenetic inhibition of LYPD1","volume":"19","author":"Chen","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.gene.2026.150438_b0155","doi-asserted-by":"crossref","first-page":"17541","DOI":"10.18632\/aging.103768","article-title":"BRD4\/8\/9 are prognostic biomarkers and associated with immune infiltrates in hepatocellular carcinoma","volume":"12","author":"Chen","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.gene.2026.150438_b0160","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41419-017-0090-8","article-title":"Hepatic SMARCA4 predicts HCC recurrence and promotes tumour cell proliferation by regulating SMAD6 expression","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150438_b0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052551","article-title":"Transposable elements and human diseases: mechanisms and implication in the response to environmental pollutants","volume":"23","author":"Chenais, b.","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2026.150438_b0170","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ebiom.2018.08.055","article-title":"LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation","volume":"36","author":"Cheng","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.gene.2026.150438_b0175","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1021\/acschembio.5b00615","article-title":"Small molecule targeting of a MicroRNA associated with hepatocellular carcinoma","volume":"11","author":"Childs-Disney","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.gene.2026.150438_b0180","doi-asserted-by":"crossref","first-page":"11799","DOI":"10.1038\/s41598-021-91284-2","article-title":"BET inhibitor suppresses migration of human hepatocellular carcinoma by inhibiting SMARCA4","volume":"11","author":"Choi","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2026.150438_b0185","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.biochem.77.062706.153223","article-title":"The biology of chromatin remodeling complexes","volume":"78","author":"Clapier","year":"2009","journal-title":"Annu. Rev. Biochem"},{"key":"10.1016\/j.gene.2026.150438_b0190","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nrm.2017.26","article-title":"Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes","volume":"18","author":"Clapier","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.gene.2026.150438_b0195","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tibs.2008.10.010","article-title":"The INO80 chromatin remodeling complex in transcription, replication and repair","volume":"34","author":"Conaway","year":"2009","journal-title":"Trends Biochem. Sci"},{"key":"10.1016\/j.gene.2026.150438_b0200","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1038\/onc.2009.211","article-title":"Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties","volume":"28","author":"Coulouarn","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2026.150438_b0205","doi-asserted-by":"crossref","unstructured":"DAIGE, C., PRIDDY, L., WIGGINS, J., NELLIGAN-DAVIS, T., ENZLER, D., VADNAGARA, K. & BROWN, D. MRX34, a liposomal miR-34 mimic and potential first-in-class microRNA therapeutic: activity in animal models of liver cancer. Journal of Clinical Oncology, 34, e14076-e14076.","DOI":"10.1200\/JCO.2016.34.15_suppl.e14076"},{"key":"10.1016\/j.gene.2026.150438_b0210","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/annonc\/mdn782","article-title":"MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events","volume":"20","author":"de Vogel","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.gene.2026.150438_b0215","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2147\/JHC.S336858","article-title":"Wnt\/beta-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways","volume":"8","author":"Deldar abad paskeh, m., mirzaei, s., ashrafizadeh, m., zarrabi, a. & sethi, g.","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.gene.2026.150438_b0220","first-page":"285","article-title":"The pan-deacetylase inhibitor panobinostat inhibits growth of hepatocellular carcinoma models by alternative pathways of apoptosis","volume":"32","author":"di Fazio","year":"2010","journal-title":"Cell. Oncol."},{"issue":"845\u2013854","key":"10.1016\/j.gene.2026.150438_b0225","first-page":"e5","article-title":"FMRP Modulates Neural Differentiation through m(6)A-Dependent mRNA Nuclear Export","volume":"28","author":"Edens","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.gene.2026.150438_b0230","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1158\/0008-5472.CAN-20-2147","article-title":"EZH2-Targeted Therapies in Cancer: Hype or a Reality","volume":"80","author":"Eich","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2026.150438_b0235","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5114\/ceh.2022.116820","article-title":"Circulating HOTAIR potentially predicts hepatocellular carcinoma in cirrhotic liver and prefigures the tumor stage","volume":"8","author":"El-Shendidi","year":"2022","journal-title":"Clin Exp Hepatol"},{"key":"10.1016\/j.gene.2026.150438_b0240","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2147\/JHC.S107370","article-title":"Hepatocellular carcinoma: early-stage management challenges","volume":"4","author":"Erstad","year":"2017","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.gene.2026.150438_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114446","article-title":"Discovery of a potent, selective and cell active inhibitor of m(6)A demethylase ALKBH5","volume":"238","author":"Fang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.gene.2026.150438_b0250","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/08977194.2016.1169532","article-title":"Abrogating the interplay between IGF2BP1, 2 and 3 and IGF1R by let-7i arrests hepatocellular carcinoma growth","volume":"34","author":"Fawzy","year":"2016","journal-title":"Growth Factors"},{"key":"10.1016\/j.gene.2026.150438_b0255","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3163955","article-title":"ARID1A Is a Prognostic Biomarker and Associated with Immune Infiltrates in Hepatocellular Carcinoma","volume":"2022","author":"Feng","year":"2022","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.gene.2026.150438_b0260","article-title":"Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg","volume":"2","author":"Fernandez-Barrena","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.gene.2026.150438_b0265","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41419-021-03827-0","article-title":"Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity","volume":"12","author":"Fernandez-Tussy","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150438_b0270","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1136248","article-title":"ARID1A in cancer: Friend or foe?","volume":"13","author":"Fontana","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.gene.2026.150438_b0275","doi-asserted-by":"crossref","first-page":"57","DOI":"10.35946\/arcr.v35.1.07","article-title":"Epigenetic events in liver cancer resulting from alcoholic liver disease","volume":"35","author":"French, s. w.","year":"2013","journal-title":"Alcohol Res."},{"key":"10.1016\/j.gene.2026.150438_b0280","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41392-025-02340-6","article-title":"Epigenetic regulation of cancer stemness","volume":"10","author":"Galassi","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.gene.2026.150438_b0285","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114351","article-title":"YAP\/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis","volume":"13","author":"Gao","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.gene.2026.150438_b0290","first-page":"3305","article-title":"Diagnostic utility of plasma lncRNA small nucleolar RNA host gene 1 in patients with hepatocellular carcinoma","volume":"18","author":"Gao","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.gene.2026.150438_b0295","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1007\/s00018-016-2184-3","article-title":"Chromatin remodeling effects on enhancer activity","volume":"73","author":"Garcia-Gonzalez","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.gene.2026.150438_b0300","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30774","article-title":"EZH2 is a key component of hepatoblastoma tumor cell growth","volume":"71","author":"Glaser","year":"2024","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.gene.2026.150438_b0305","doi-asserted-by":"crossref","first-page":"11512","DOI":"10.1038\/s41598-022-15058-0","article-title":"DNA methylation fingerprint of hepatocellular carcinoma from tissue and liquid biopsies","volume":"12","author":"Goncalves","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2026.150438_b0310","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.cgh.2013.09.053","article-title":"Factors that affect accuracy of alpha-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis","volume":"12","author":"Gopal","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.gene.2026.150438_b0315","doi-asserted-by":"crossref","first-page":"61475","DOI":"10.18632\/oncotarget.18424","article-title":"RUNX3 regulates hepatocellular carcinoma cell metastasis via targeting miR-186\/E-cadherin\/EMT pathway","volume":"8","author":"Gou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.gene.2026.150438_b0320","doi-asserted-by":"crossref","first-page":"8466","DOI":"10.1128\/MCB.00993-07","article-title":"Mammalian ASH1L is a histone methyltransferase that occupies the transcribed region of active genes","volume":"27","author":"Gregory","year":"2007","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.gene.2026.150438_b0325","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13578-022-00835-1","article-title":"DNA methyltransferase 1 knockdown reverses PTEN and VDR by mediating demethylation of promoter and protects against renal injuries in hepatitis B virus-associated glomerulonephritis","volume":"12","author":"Guan","year":"2022","journal-title":"Cell Biosci."},{"key":"10.1016\/j.gene.2026.150438_b0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242191","article-title":"EZH2 is a negative prognostic biomarker associated with immunosuppression in hepatocellular carcinoma","volume":"15","author":"Guo","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2026.150438_b0335","doi-asserted-by":"crossref","first-page":"e1652","DOI":"10.1002\/ctm2.1652","article-title":"Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort study","volume":"14","author":"Guo","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.gene.2026.150438_b0340","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13072-025-00572-y","article-title":"Post-translational modifications of epigenetic modifier TIP60: their role in cellular functions and cancer","volume":"18","author":"Gupta","year":"2025","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.gene.2026.150438_b0345","doi-asserted-by":"crossref","DOI":"10.3390\/cells10113257","article-title":"Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease","volume":"10","author":"Hagiwara","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.gene.2026.150438_b0350","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092622","article-title":"Epigenetic Associations between lncRNA\/circRNA and miRNA in Hepatocellular Carcinoma","volume":"12","author":"Han","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.gene.2026.150438_b0355","doi-asserted-by":"crossref","DOI":"10.3390\/cimb48040360","article-title":"Novel lncRNA Signature (UFC1\/PTENP1) as a Molecular Biomarker for the Diagnosis and Prognosis of Hepatocellular Carcinoma in an Egyptian Cohort","volume":"48","author":"Hassan","year":"2026","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.gene.2026.150438_b0360","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.31557\/APJCP.2020.21.11.3357","article-title":"DNA Methyltransferases as Potential Biomarkers for HCV Related Hepatocellular Carcinoma","volume":"21","author":"Hassouna","year":"2020","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.gene.2026.150438_b0365","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.humpath.2011.11.003","article-title":"High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma","volume":"43","author":"He","year":"2012","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.gene.2026.150438_b0370","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67312","article-title":"YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation","volume":"10","author":"He","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.gene.2026.150438_b0375","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s12672-025-03496-x","article-title":"Systematic analysis identifies CDKN2A as a prognostic biomarker for hepatocellular carcinoma","volume":"16","author":"He","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.gene.2026.150438_b0380","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2014.07.018","article-title":"Vulnerabilities of mutant SWI\/SNF complexes in cancer","volume":"26","author":"Helming","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.gene.2026.150438_b0385","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/hep.30211","article-title":"Integrating the Epigenome to Identify Drivers of Hepatocellular Carcinoma","volume":"69","author":"Hlady","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.gene.2026.150438_b0390","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.gene.2026.150438_b0395","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cellimm.2018.12.010","article-title":"Epigenetic modulation enhances immunotherapy for hepatocellular carcinoma","volume":"336","author":"Hong","year":"2019","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.gene.2026.150438_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101248","article-title":"Wilms' tumor 1-associating protein complex regulates alternative splicing and polyadenylation at potential G-quadruplex-forming splice site sequences","volume":"297","author":"Horiuchi","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2026.150438_b0405","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/cr.2016.23","article-title":"Single-cell triple omics sequencing reveals genetic, epigenetic, and transcriptomic heterogeneity in hepatocellular carcinomas","volume":"26","author":"Hou","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.gene.2026.150438_b0410","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40265-020-01288-x","article-title":"Tazemetostat: First Approval","volume":"80","author":"Hoy, s. m.","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.gene.2026.150438_b0415","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41598-019-56691-6","article-title":"Multiple gene promoter methylation and clinical stage in adjacent normal tissues: Effect on prognosis of colorectal cancer in Taiwan","volume":"10","author":"Hsu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2026.150438_b0420","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12791","article-title":"The roles of mutated SWI\/SNF complexes in the initiation and development of hepatocellular carcinoma and its regulatory effect on the immune system: A review","volume":"53","author":"Hu","year":"2020","journal-title":"Cell Prolif."},{"key":"10.1016\/j.gene.2026.150438_b0425","doi-asserted-by":"crossref","first-page":"23","DOI":"10.14715\/10.14715\/cmb\/2019.65.4.4","article-title":"Clinical significance of HDAC9 in hepatocellular carcinoma","volume":"65","author":"Hu","year":"2019","journal-title":"Cell. Mol. Biol. (Noisy-le-Grand)"},{"key":"10.1016\/j.gene.2026.150438_b0430","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.7150\/thno.42174","article-title":"Circular RNA-protein interactions: functions, mechanisms, and identification","volume":"10","author":"Huang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.gene.2026.150438_b0435","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1128\/MCB.01365-08","article-title":"Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA","volume":"29","author":"Huang","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.gene.2026.150438_b0440","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1158\/2159-8290.CD-25-0587","article-title":"Priming with DNMT Inhibitors Potentiates PD-1 Immunotherapy by Triggering Viral Mimicry in Relapsed\/Refractory NK\/T-cell Lymphoma","volume":"15","author":"Huang","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.gene.2026.150438_b0445","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.gene.2026.150438_b0450","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jare.2025.07.006","article-title":"Redistribution of super-enhancers promotes malignancy in human hepatocellular carcinoma","volume":"82","author":"Huang","year":"2026","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.gene.2026.150438_b0455","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.bjc.6606010","article-title":"The role of microRNAs in liver cancer progression","volume":"104","author":"Huang","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.gene.2026.150438_b0460","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.stemcr.2016.05.014","article-title":"Regulation of the DNA Methylation Landscape in Human Somatic Cell Reprogramming by the miR-29 Family","volume":"7","author":"Hysolli","year":"2016","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.gene.2026.150438_b0465","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10637-018-0634-5","article-title":"Phase I study of resminostat, an HDAC inhibitor, combined with S-1 in patients with pre-treated biliary tract or pancreatic cancer","volume":"37","author":"Ikeda","year":"2019","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.gene.2026.150438_b0470","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/cac2.70049","article-title":"Coordinated gene expression within sustained STAT3-associated chromatin conformations contributes to hepatocellular carcinoma progression","volume":"45","author":"Jang","year":"2025","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.gene.2026.150438_b0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2022.101989","article-title":"KDM1A drives hepatoblastoma progression by activating the Wnt\/beta-catenin pathway through inhibition of DKK3 transcription","volume":"81","author":"Ji","year":"2023","journal-title":"Tissue Cell"},{"key":"10.1016\/j.gene.2026.150438_b0480","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nchembio.687","article-title":"N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO","volume":"7","author":"Jia","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.gene.2026.150438_b0485","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5576683","article-title":"Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response","volume":"2021","author":"Jiang","year":"2021","journal-title":"Dis. Markers"},{"key":"10.1016\/j.gene.2026.150438_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116375","article-title":"Targeting FTO suppresses hepatocellular carcinoma by inhibiting ERBB3 and TUBB4A expression","volume":"226","author":"Jiang","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.gene.2026.150438_b0495","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1007\/s00018-019-03222-1","article-title":"Long non-coding RNA PVT1 interacts with MYC and its downstream molecules to synergistically promote tumorigenesis","volume":"76","author":"Jin","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.gene.2026.150438_b0500","doi-asserted-by":"crossref","first-page":"10464","DOI":"10.1038\/s41598-019-46872-8","article-title":"Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma","volume":"9","author":"Jin","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2026.150438_b0505","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/15592294.2016.1214781","article-title":"Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma","volume":"11","author":"Jueliger","year":"2016","journal-title":"Epigenetics"},{"key":"10.1016\/j.gene.2026.150438_b0510","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11030654","article-title":"Epigenetic Regulators of DNA Cytosine Modification: Promising Targets for Cancer Therapy","volume":"11","author":"Jung","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.gene.2026.150438_b0515","doi-asserted-by":"crossref","first-page":"104","DOI":"10.17998\/jlc.2025.11.29","article-title":"Exploring single-cell and multi-omics technologies and their role in unraveling tumor heterogeneity of hepatocellular carcinoma","volume":"26","author":"Jyotishi","year":"2026","journal-title":"J Liver Cancer"},{"key":"10.1016\/j.gene.2026.150438_b0520","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1634\/theoncologist.10-3-176","article-title":"FDA drug approval summary: azacitidine (5-azacytidine, Vidaza) for injectable suspension","volume":"10","author":"Kaminskas","year":"2005","journal-title":"Oncologist"},{"key":"10.1016\/j.gene.2026.150438_b0525","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2024.1434002","article-title":"Precision oncology revolution: CRISPR-Cas9 and PROTAC technologies unleashed","volume":"15","author":"Kanbar","year":"2024","journal-title":"Front. Genet."},{"key":"10.1016\/j.gene.2026.150438_b0530","article-title":"Tumor Suppressive Effects of GAS5 in Cancer Cells. Noncoding","volume":"8","author":"Kaur","year":"2022","journal-title":"RNA"},{"key":"10.1016\/j.gene.2026.150438_b0535","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4331\/wjbc.v6.i4.333","article-title":"Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment?","volume":"6","author":"Khan","year":"2015","journal-title":"World J. Biol. Chem."},{"key":"10.1016\/j.gene.2026.150438_b0540","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ajhg.2008.09.005","article-title":"Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome","volume":"83","author":"Kim","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.gene.2026.150438_b0545","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.embor.7400625","article-title":"Tudor, MBT and chromo domains gauge the degree of lysine methylation","volume":"7","author":"Kim","year":"2006","journal-title":"EMBO Rep."},{"key":"10.1016\/j.gene.2026.150438_b0550","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12943-023-01872-1","article-title":"A circulating cell-free DNA methylation signature for the detection of hepatocellular carcinoma","volume":"22","author":"Kim","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.gene.2026.150438_b0555","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018622","article-title":"Enhancer RNAs: a class of long noncoding RNAs synthesized at enhancers","volume":"7","author":"Kim","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.gene.2026.150438_b0560","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/hep.30244","article-title":"Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation","volume":"69","author":"Kisiel","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.gene.2026.150438_b0565","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00018-017-2721-8","article-title":"The TET enzymes","volume":"75","author":"Koivunen","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.gene.2026.150438_b0570","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1111\/febs.16580","article-title":"BRD4 and MYC: power couple in transcription and disease","volume":"290","author":"Kotekar","year":"2023","journal-title":"FEBS J."},{"key":"10.1016\/j.gene.2026.150438_b0575","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004669","article-title":"Chromatin remodeling (SWI\/SNF) complexes, cancer, and response to immunotherapy","volume":"10","author":"Krishnamurthy","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.gene.2026.150438_b0585","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.5114\/aoms.2019.86613","article-title":"MicroRNA profile and iron-related gene expression in hepatitis C-related hepatocellular carcinoma: a preliminary study","volume":"17","author":"Krupa","year":"2021","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.gene.2026.150438_b0580","doi-asserted-by":"crossref","unstructured":"K. Krupa M. Fudalej A. Cencelewicz-Lesikow A. Badowska-Kozakiewicz A. Czerw A. Deptala Current Treatment Methods in Hepatocellular Carcinoma 2024 Cancers (Basel) 16.","DOI":"10.3390\/cancers16234059"},{"key":"10.1016\/j.gene.2026.150438_b0590","doi-asserted-by":"crossref","first-page":"21396","DOI":"10.1038\/s41598-021-00889-0","article-title":"EZH1\/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma","volume":"11","author":"Kusakabe","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2026.150438_b0595","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1111\/cas.16186","article-title":"EZH2 suppresses ferroptosis in hepatocellular carcinoma and reduces sorafenib sensitivity through epigenetic regulation of TFR2","volume":"115","author":"Lai","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.gene.2026.150438_b0600","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12943-019-1106-z","article-title":"KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3","volume":"18","author":"Lan","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.gene.2026.150438_b0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175736","article-title":"5-Azacytidine promotes HCC cell metastasis by up-regulating RDH16 expression","volume":"950","author":"Le","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.gene.2026.150438_b0610","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.3892\/or.2015.4263","article-title":"HDAC1 and HDAC2 independently predict mortality in hepatocellular carcinoma by a competing risk regression model in a Southeast Asian population","volume":"34","author":"Ler","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.gene.2026.150438_b0615","doi-asserted-by":"crossref","first-page":"192","DOI":"10.21037\/tcr-2025-aw-2523","article-title":"Extracellular vesicle-derived lncRNA-NEAT1 serves as potential biomarker for the early diagnosis of hepatocellular carcinoma","volume":"15","author":"Li","year":"2026","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.gene.2026.150438_b0620","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.gendis.2020.11.014","article-title":"The paradoxical functions of long noncoding RNAs in hepatocellular carcinoma: Implications in therapeutic opportunities and precision medicine","volume":"9","author":"Li","year":"2022","journal-title":"Genes Dis"},{"key":"10.1016\/j.gene.2026.150438_b0625","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.18632\/oncotarget.6275","article-title":"Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.gene.2026.150438_b0630","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature04802","article-title":"Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF","volume":"442","author":"Li","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.gene.2026.150438_b0635","article-title":"Comprehensive Analysis of Histone Modifications in Hepatocellular Carcinoma Reveals Different Subtypes and Key Prognostic Models","volume":"2022","author":"Li","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.gene.2026.150438_b0640","article-title":"HDAC inhibitor MS275 reprograms metabolism to induce differentiation and suppress proliferation in hepatocellular carcinoma","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.gene.2026.150438_b0645","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.4251\/wjgo.v14.i8.1574","article-title":"RASSF1A methylation as a biomarker for detection of colorectal cancer and hepatocellular carcinoma","volume":"14","author":"Li","year":"2022","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.gene.2026.150438_b0650","first-page":"6084","article-title":"m6A demethylase FTO promotes hepatocellular carcinoma tumorigenesis via mediating PKM2 demethylation","volume":"11","author":"Li","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.gene.2026.150438_b0655","article-title":"Correlation and clinical significance of GSTP1 hypermethylation in hepatocellular carcinoma: a systematic review and meta-analysis","volume":"16","author":"Li","year":"2025","journal-title":"Front. Genet."},{"key":"10.1016\/j.gene.2026.150438_b0660","article-title":"Nanodelivery of panobinostat induces cell cycle arrest and apoptosis to suppress hepatocellular carcinoma growth in mice","volume":"35","author":"Li","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.gene.2026.150438_b0665","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026831","article-title":"HDACs and HDAC Inhibitors in Cancer Development and Therapy","volume":"6","author":"Li","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.gene.2026.150438_b0670","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1042\/CBI20100851","article-title":"Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma","volume":"36","author":"Li","year":"2012","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.gene.2026.150438_b0675","article-title":"WTAP Is Correlated With Unfavorable Prognosis, Tumor Cell Proliferation, and Immune Infiltration in Hepatocellular Carcinoma","volume":"12","author":"Liang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.gene.2026.150438_b0680","article-title":"Prognostic value of long non-coding RNA MALAT1 in hepatocellular carcinoma: A study based on multi-omics analysis and RT-PCR validation","volume":"28","author":"Liao","year":"2022","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.gene.2026.150438_b0685","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41416-025-02969-8","article-title":"The epigenetic basis of hepatocellular carcinoma \u2013 mechanisms and potential directions for biomarkers and therapeutics","volume":"132","author":"Lin","year":"2025","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.gene.2026.150438_b0690","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41416-025-02969-8","article-title":"The epigenetic basis of hepatocellular carcinoma - mechanisms and potential directions for biomarkers and therapeutics","volume":"132","author":"Lin","year":"2025","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.gene.2026.150438_b0695","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.clinre.2015.11.005","article-title":"Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage","volume":"40","author":"Lin","year":"2016","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.gene.2026.150438_b0700","article-title":"GNMT and Its Regulatory MicroRNAs as Biomarkers and Therapeutic Targets for Metabolic Dysfunction-Associated Fatty Liver Disease and Hepatocellular Carcinoma","volume":"27","author":"Lin","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2026.150438_b0705","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrd4140","article-title":"MicroRNAs and other non-coding RNAs as targets for anticancer drug development","volume":"12","author":"Ling","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.gene.2026.150438_b0710","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2010.02.021","article-title":"MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma","volume":"53","author":"Liu","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.gene.2026.150438_b0715","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13046-018-0806-3","article-title":"Ajuba inhibits hepatocellular carcinoma cell growth via targeting of beta-catenin and YAP signaling and is regulated by E3 ligase Hakai through neddylation","volume":"37","author":"Liu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.gene.2026.150438_b0720","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12935-023-03096-1","article-title":"Therapeutic effect and transcriptome-methylome characteristics of METTL3 inhibition in liver hepatocellular carcinoma","volume":"23","author":"Liu","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.gene.2026.150438_b0725","doi-asserted-by":"crossref","first-page":"315","DOI":"10.7150\/jca.102618","article-title":"WTAP regulates Mitochondrial damage and Lipid oxidation in HCC by NOA1 mediated m6A modification","volume":"16","author":"Liu","year":"2025","journal-title":"J. Cancer"},{"key":"10.1016\/j.gene.2026.150438_b0730","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1021\/acscentsci.2c00107","article-title":"Allosteric Regulation of IGF2BP1 as a Novel Strategy for the Activation of Tumor Immune Microenvironment","volume":"8","author":"Liu","year":"2022","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.gene.2026.150438_b0735","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70157","article-title":"Heat shock transcription factor 1 facilitates liver cancer progression by driving super-enhancer-mediated transcription of MYCN","volume":"13","author":"Liu","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.gene.2026.150438_b0740","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/j.csbj.2020.09.013","article-title":"Identification of key genes and important histone modifications in hepatocellular carcinoma","volume":"18","author":"Liu","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.gene.2026.150438_b0745","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/2767-9764.CRC-21-0142","article-title":"Methylated Septin9 (mSEPT9): A promising blood-based biomarker for the detection and screening of early-onset colorectal cancer","volume":"2","author":"Loomans-Kropp","year":"2022","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.gene.2026.150438_b0750","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","article-title":"Selective inhibition of tumor oncogenes by disruption of super-enhancers","volume":"153","author":"Loven","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.gene.2026.150438_b0755","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12935-024-03599-5","article-title":"Super-enhancers in hepatocellular carcinoma: regulatory mechanism and therapeutic targets","volume":"25","author":"Lu","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.gene.2026.150438_b0760","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12865-020-0337-5","article-title":"The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer","volume":"21","author":"Luker","year":"2020","journal-title":"BMC Immunol."},{"key":"10.1016\/j.gene.2026.150438_b0765","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12916-021-02201-3","article-title":"Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma","volume":"20","author":"Luo","year":"2022","journal-title":"BMC Med."},{"key":"10.1016\/j.gene.2026.150438_b0770","doi-asserted-by":"crossref","first-page":"13834","DOI":"10.1073\/pnas.1412742111","article-title":"Molecular basis for the recognition of methylated adenines in RNA by the eukaryotic YTH domain","volume":"111","author":"Luo","year":"2014","journal-title":"PNAS"},{"key":"10.1016\/j.gene.2026.150438_b0775","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40164-021-00227-0","article-title":"YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K\/AKT\/mTOR signaling pathway and inducing epithelial-mesenchymal transition","volume":"10","author":"Luo","year":"2021","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.gene.2026.150438_b0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116365","article-title":"N(6)-methyladenosine (m(6)A) modification in hepatocellular carcinoma","volume":"173","author":"Ma","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.gene.2026.150438_b0785","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41598-024-84050-7","article-title":"ALKBH5 acts a tumor-suppressive biomarker and is associated with immunotherapy response in hepatocellular carcinoma","volume":"15","author":"Ma","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2026.150438_b0790","article-title":"Prognostic effect of DNA methylation of BTG2 gene in Chinese hepatocellular carcinoma","volume":"10","author":"Ma","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.gene.2026.150438_b0795","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092415","article-title":"The Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness","volume":"10","author":"Ma","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.gene.2026.150438_b0800","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41573-024-00978-5","article-title":"Chromatin remodellers as therapeutic targets","volume":"23","author":"Malone","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.gene.2026.150438_b0805","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","article-title":"FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma","volume":"12","author":"Mann","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.gene.2026.150438_b0810","first-page":"30","article-title":"The Chd family of chromatin remodelers","volume":"618","author":"Marfella","year":"2007","journal-title":"Mutat. Res."},{"key":"10.1016\/j.gene.2026.150438_b0815","doi-asserted-by":"crossref","first-page":"16698","DOI":"10.18632\/oncotarget.3677","article-title":"An open-label, single-arm, phase I\/II study of lower-dose decitabine based therapy in patients with advanced hepatocellular carcinoma","volume":"6","author":"Mei","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.gene.2026.150438_b0820","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/2211-5463.13734","article-title":"The efficacy of sorafenib against hepatocellular carcinoma is enhanced by 5-aza-mediated inhibition of ID1 promoter methylation","volume":"14","author":"Meng","year":"2024","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.gene.2026.150438_b0825","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bbagrm.2018.10.006","article-title":"m(6)A-mediated translation regulation","volume":"1862","author":"Meyer, k. d.","year":"2019","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.gene.2026.150438_b0830","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41418-022-00948-7","article-title":"Specific expression and functions of circular RNAs","volume":"29","author":"Misir","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.gene.2026.150438_b0835","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.gene.2026.150438_b0840","doi-asserted-by":"crossref","unstructured":"MORISHITA, A., OURA, K., TADOKORO, T., FUJITA, K., TANI, J. & MASAKI, T. 2026. Correction: Morishita et al. MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review. Cancers 2021, 13, 514. Cancers (Basel), 18.","DOI":"10.3390\/cancers18020232"},{"key":"10.1016\/j.gene.2026.150438_b0845","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.molcel.2008.10.026","article-title":"HP1 proteins form distinct complexes and mediate heterochromatic gene silencing by nonoverlapping mechanisms","volume":"32","author":"Motamedi","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.gene.2026.150438_b0850","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.3748\/wjg.v23.i32.5860","article-title":"Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications","volume":"23","author":"Niu","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.gene.2026.150438_b0855","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/onc.2009.19","article-title":"miR-449a targets HDAC-1 and induces growth arrest in prostate cancer","volume":"28","author":"Noonan","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2026.150438_b0860","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00432-004-0664-6","article-title":"The histone-deacetylase inhibitor SAHA potentiates proapoptotic effects of 5-fluorouracil and irinotecan in hepatoma cells","volume":"131","author":"Ocker","year":"2005","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.gene.2026.150438_b0865","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00280-024-04658-4","article-title":"Pharmacology and pharmacokinetics of tazemetostat","volume":"93","author":"Orleni","year":"2024","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.gene.2026.150438_b0870","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/jamaoncol.2026.2157","article-title":"Circulating Methylated SEPT9 for Detection of Hepatocellular Carcinoma in Cirrhosis","volume":"12","author":"Oussalah, a., silva rodriguez, m., conroy, g., bensenane, m., rousseau, h., ayav, a., gueant, j. l., camara, h., baumann, c., laurent, v., bronowicki, j. p. & group, s. c. s.","year":"2026","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.gene.2026.150438_b0875","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3892\/ol.2012.951","article-title":"The pan-deacetylase inhibitor panobinostat modulates the expression of epithelial-mesenchymal transition markers in hepatocellular carcinoma models","volume":"5","author":"P, d. i. f., montalbano, r., quint, k., alinger, b., kemmerling, r., kiesslich, t., ocker, m. & neureiter, d.","year":"2013","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.gene.2026.150438_b0880","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13072-021-00400-z","article-title":"Losing DNA methylation at repetitive elements and breaking bad","volume":"14","author":"Pappalardo","year":"2021","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.gene.2026.150438_b0885","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.canlet.2005.03.017","article-title":"DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma","volume":"233","author":"Park","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.gene.2026.150438_b0890","doi-asserted-by":"crossref","first-page":"32","DOI":"10.21037\/cco-2026-1-0022","article-title":"Genome-wide 5-hydroxymethylcytosine in circulating cell-free DNA reflects DNA methylation dynamics for non-invasive detection of early hepatocellular carcinoma","volume":"15","author":"Peng","year":"2026","journal-title":"Chin. Clin. Oncol."},{"key":"10.1016\/j.gene.2026.150438_b0895","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0092-8674(75)90159-2","article-title":"The methylated constituents of L cell messenger RNA: evidence for an unusual cluster at the 5' terminus","volume":"4","author":"Perry","year":"1975","journal-title":"Cell"},{"key":"10.1016\/j.gene.2026.150438_b0900","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s00018-009-0015-5","article-title":"DNA hypomethylation in the origin and pathogenesis of human diseases","volume":"66","author":"Pogribny","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.gene.2026.150438_b0905","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1471-2407-9-163","article-title":"Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma","volume":"9","author":"Qi","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gene.2026.150438_b0910","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1007\/s00262-022-03167-8","article-title":"Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma","volume":"71","author":"Qu","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.gene.2026.150438_b0915","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1186\/s12885-021-08449-5","article-title":"A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis","volume":"21","author":"Qu","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gene.2026.150438_b0920","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41420-025-02462-4","article-title":"Acetylated KIAA1429 by TIP60 facilitates metastasis and immune evasion of hepatocellular carcinoma via N6-methyladenosine-KDM5B-mediated regulation of FoxO1","volume":"11","author":"Quan","year":"2025","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.gene.2026.150438_b0925","doi-asserted-by":"crossref","unstructured":"RAHA, P. 2016. Chapter 40 - Outcome of Combining Epigenetic Drugs with Other Treatments in the Clinic. In: TOLLEFSBOL, T. O. (ed.) Medical Epigenetics. Boston: Academic Press.","DOI":"10.1016\/B978-0-12-803239-8.00040-5"},{"key":"10.1016\/j.gene.2026.150438_b0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e39489","article-title":"Deciphering the multifaceted role of microRNAs in hepatocellular carcinoma: Integrating literature review and bioinformatics analysis for therapeutic insights","volume":"10","author":"Rahdan","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.gene.2026.150438_b0935","article-title":"Artificial intelligence in hepatocellular carcinoma screening: applications and challenges","volume":"12","author":"Rao","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.gene.2026.150438_b0940","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.arcmed.2022.11.003","article-title":"Cancer Epigenetics: An Overview","volume":"53","author":"Recillas-targa, f.","year":"2022","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.gene.2026.150438_b0945","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.chembiol.2014.11.021","article-title":"Small-molecule modulators of methyl-lysine binding for the CBX7 chromodomain","volume":"22","author":"Ren","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.gene.2026.150438_b0950","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1136\/gutjnl-2021-325405","article-title":"Histone H3K27 demethylase KDM6A is an epigenetic gatekeeper of mTORC1 signalling in cancer","volume":"71","author":"Revia","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.gene.2026.150438_b0955","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000111106","article-title":"Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma","volume":"72","author":"Rikimaru","year":"2007","journal-title":"Oncology"},{"key":"10.1016\/j.gene.2026.150438_b0960","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.molcel.2019.05.032","article-title":"Regulatory Landscaping: How Enhancer-Promoter Communication Is Sculpted in 3D","volume":"74","author":"Robson","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.gene.2026.150438_b0965","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/liv.15230","article-title":"Long non-coding RNA H19 as a biomarker for hepatocellular carcinoma","volume":"42","author":"Rojas","year":"2022","journal-title":"Liver Int."},{"key":"10.1016\/j.gene.2026.150438_b0970","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.1038\/s41598-025-87701-5","article-title":"METTL14 suppresses the migration and invasion of hepatocellular carcinoma cells by m6A methylation of RPLP2","volume":"15","author":"Rong","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2026.150438_b0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.adcanc.2026.100187","article-title":"Two small keys to a locked gate: miR-221\/222 unlock immune escape and chemoresistance","volume":"17","author":"Saadh","year":"2026","journal-title":"Advances in Cancer Biology - Metastasis"},{"key":"10.1016\/j.gene.2026.150438_b0980","first-page":"45","volume":"14","author":"Sanaei","year":"2020","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"10.1016\/j.gene.2026.150438_b0985","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/cas.14311","article-title":"Synthetic lethal therapy based on targeting the vulnerability of SWI\/SNF chromatin remodeling complex-deficient cancers","volume":"111","author":"Sasaki","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.gene.2026.150438_b0990","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13073-015-0134-6","article-title":"TET proteins and the control of cytosine demethylation in cancer","volume":"7","author":"Scourzic","year":"2015","journal-title":"Genome Med."},{"key":"10.1016\/j.gene.2026.150438_b0995","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.31557\/APJCP.2019.20.8.2515","article-title":"Diagnostic Performance of microRNA-122 and microRNA-224 in Hepatitis C Virus-Induced Hepatocellular Carcinoma (HCC)","volume":"20","author":"Shehab-Eldeen","year":"2019","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.gene.2026.150438_b1000","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/hep.25569","article-title":"Genome-wide DNA methylation profiles in hepatocellular carcinoma","volume":"55","author":"Shen","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.gene.2026.150438_b1005","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101181","article-title":"5-methylcytosine methylation of MALAT1 promotes resistance to sorafenib in hepatocellular carcinoma through ELAVL1\/SLC7A11-mediated ferroptosis","volume":"78","author":"Shi","year":"2025","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.gene.2026.150438_b1010","article-title":"The epigenetic regulatory network of long noncoding RNAs in hepatocellular carcinoma","volume":"12","author":"Shi","year":"2025","journal-title":"Genes Dis"},{"key":"10.1016\/j.gene.2026.150438_b1015","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jhep.2009.12.024","article-title":"The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma","volume":"52","author":"Shimizu","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.gene.2026.150438_b1020","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1002\/hep4.2045","article-title":"Comparison of a multitarget blood test to ultrasound and alpha-fetoprotein for hepatocellular carcinoma surveillance: Results of a network meta-analysis","volume":"6","author":"Singal","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.gene.2026.150438_b1025","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.642443","article-title":"Dynamics of m6A RNA Methylome on the Hallmarks of Hepatocellular Carcinoma","volume":"9","author":"Sivasudhan","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.gene.2026.150438_b1030","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1089\/scd.2009.0309","article-title":"Lineage-specific promoter DNA methylation patterns segregate adult progenitor cell types","volume":"19","author":"Sorensen","year":"2010","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.gene.2026.150438_b1035","doi-asserted-by":"crossref","first-page":"110367","DOI":"10.18632\/oncotarget.22775","article-title":"Resminostat induces changes in epithelial plasticity of hepatocellular carcinoma cells and sensitizes them to sorafenib-induced apoptosis","volume":"8","author":"Soukupova","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.gene.2026.150438_b1040","doi-asserted-by":"crossref","first-page":"158","DOI":"10.6004\/jadpro.2022.13.2.7","article-title":"Tazemetostat: EZH2 Inhibitor","volume":"13","author":"Straining","year":"2022","journal-title":"J. Adv. Pract. Oncol."},{"key":"10.1016\/j.gene.2026.150438_b1045","doi-asserted-by":"crossref","first-page":"9587","DOI":"10.1038\/s41598-021-88983-1","article-title":"Histone deacetylase inhibitor resminostat in combination with sorafenib counteracts platelet-mediated pro-tumoral effects in hepatocellular carcinoma","volume":"11","author":"Streubel","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2026.150438_b1050","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70066","article-title":"Comprehensive review and updated analysis of DNA methylation in hepatocellular carcinoma: From basic research to clinical application","volume":"14","author":"Su","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.gene.2026.150438_b1055","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12016-024-09011-4","article-title":"Regulatory Roles of SWI\/SNF Chromatin Remodeling Complexes in Immune Response and Inflammatory Diseases","volume":"68","author":"Sun","year":"2024","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.gene.2026.150438_b1060","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/cas.12498","article-title":"Silencing of microRNA-122 is an early event during hepatocarcinogenesis from non-alcoholic steatohepatitis","volume":"105","author":"Takaki","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.gene.2026.150438_b1065","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41597-023-02001-9","article-title":"A dataset of definitive endoderm and hepatocyte differentiations from human induced pluripotent stem cells","volume":"10","author":"Tanaka","year":"2023","journal-title":"Sci. Data"},{"key":"10.1016\/j.gene.2026.150438_b1070","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.2147\/JHC.S554181","article-title":"EZH2: From Oncogenic Driver to Therapeutic Target for Overcoming Drug Resistance in Hepatocellular Carcinoma","volume":"12","author":"Tang","year":"2025","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.gene.2026.150438_b1075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0304-3835(00)00518-8","article-title":"Hypomethylation and overexpression of c-jun and c-myc protooncogenes and increased DNA methyltransferase activity in dichloroacetic and trichloroacetic acid-promoted mouse liver tumors","volume":"158","author":"Tao","year":"2000","journal-title":"Cancer Lett."},{"key":"10.1016\/j.gene.2026.150438_b1080","article-title":"Epigenetic modification-related mechanisms of hepatocellular carcinoma resistance to immune checkpoint inhibition","volume":"13","author":"Tao","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.gene.2026.150438_b1085","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.3748\/wjg.v18.i19.2334","article-title":"Anti-tumor effect of 5-aza-2'-deoxycytidine by inhibiting telomerase activity in hepatocellular carcinoma cells","volume":"18","author":"Tao","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.gene.2026.150438_b1090","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12250-015-3582-7","article-title":"Genetic and epigenetic alterations in hepatitis B virus-associated hepatocellular carcinoma","volume":"30","author":"Tian","year":"2015","journal-title":"Virol. Sin."},{"key":"10.1016\/j.gene.2026.150438_b1095","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14071630","article-title":"5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p\/ROCK2 Pathway","volume":"14","author":"Tonon","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.gene.2026.150438_b1100","first-page":"175","article-title":"Diverse involvement of EZH2 in cancer epigenetics","volume":"7","author":"Volkel","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.gene.2026.150438_b1105","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1182\/blood.V116.21.2811.2811","article-title":"Resminostat In Relapsed or Refractory Hodgkin Lymphoma: Initial Results of the SAPHIRE Phase II Trial with a Novel Oral Histone Deacetylase (HDAC) Inhibitor","volume":"116","author":"Walewski","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.gene.2026.150438_b1110","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.3389\/fphys.2018.01918","article-title":"Methylation in MIRLET7A3 Gene Induces the Expression of IGF-II and Its mRNA Binding Proteins IGF2BP-2 and 3 in Hepatocellular Carcinoma","volume":"9","author":"Waly","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.gene.2026.150438_b1115","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.bbrc.2018.04.173","article-title":"Long noncoding RNA HOTTIP cooperates with CCCTC-binding factor to coordinate HOXA gene expression","volume":"500","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.gene.2026.150438_b1120","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1111\/jcmm.17997","article-title":"KIAA1429 protects hepatocellular carcinoma cells from ferroptotic cell death with a m(6) A-dependent posttranscriptional modification of SLC7A11","volume":"27","author":"Wang","year":"2023","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.gene.2026.150438_b1125","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.156333","article-title":"WTAP contributes to the malignancy and stemness of hepatocellular carcinoma through upregulating N6-methyladenosine modification of ITGB4","volume":"278","author":"Wang","year":"2026","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.gene.2026.150438_b1130","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s13046-023-02855-2","article-title":"EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A","volume":"42","author":"Wang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.gene.2026.150438_b1135","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nature09819","article-title":"A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.gene.2026.150438_b1140","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41401-025-01631-6","article-title":"ALKBH5 deficiency suppresses hepatocarcinogenesis in mice via m(6)A-dependent STAT1 restoration","volume":"47","author":"Wang","year":"2026","journal-title":"Acta Pharmacol. Sin."},{"issue":"1294\u20131308","key":"10.1016\/j.gene.2026.150438_b1145","first-page":"e8","article-title":"YTHDF2 inhibition potentiates radiotherapy antitumor efficacy","volume":"41","author":"Wang","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.gene.2026.150438_b1150","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41392-025-02436-z","article-title":"Deciphering the regulatory landscape of enhancer RNAs in health and disease","volume":"11","author":"Wang","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.gene.2026.150438_b1155","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1328444","article-title":"ZC3H13 Inhibits the Progression of Hepatocellular Carcinoma through m(6)A-PKM2-Mediated Glycolysis and Enhances Chemosensitivity","volume":"2021","author":"Wang","year":"2021","journal-title":"J. Oncol."},{"key":"10.1016\/j.gene.2026.150438_b1160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40164-022-00370-2","article-title":"ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner","volume":"12","author":"Wang","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.gene.2026.150438_b1165","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.1016\/j.apsb.2025.10.004","article-title":"m(6)A readers: Promising therapeutic targets in cancer treatment","volume":"15","author":"Wang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.gene.2026.150438_b1170","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.21037\/atm-22-5964","article-title":"N6-methyladenosine methylation-related genes YTHDF2, METTL3, and ZC3H13 predict the prognosis of hepatocellular carcinoma patients","volume":"10","author":"Wang","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.gene.2026.150438_b1175","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.21037\/jgo-2025-363","article-title":"YTHDF1 regulates YTHDF2 stability via m6A-dependent mechanisms in hepatocellular carcinoma: insights from in vitro, in vivo, and multi-cohort clinical studies","volume":"16","author":"Wang","year":"2025","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.gene.2026.150438_b1180","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41392-023-01647-6","article-title":"Bromodomain and extraterminal (BET) proteins: biological functions, diseases, and targeted therapy","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.gene.2026.150438_b1185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/or.2016.5236","article-title":"Non-coding RNAs as regulators in epigenetics (Review)","volume":"37","author":"Wei","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.gene.2026.150438_b1190","doi-asserted-by":"crossref","DOI":"10.1177\/0300060520941634","article-title":"MicroRNA-122 as a diagnostic biomarker for hepatocellular carcinoma related to hepatitis C virus: a meta-analysis and systematic review","volume":"48","author":"Wei","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.gene.2026.150438_b1195","doi-asserted-by":"crossref","first-page":"10216","DOI":"10.1111\/jcmm.15635","article-title":"Circulating circRNA predicting the occurrence of hepatocellular carcinoma in patients with HBV infection","volume":"24","author":"Wu","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.gene.2026.150438_b1200","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3892\/ol.2017.6312","article-title":"Role of the long non-coding RNA HOTAIR in hepatocellular carcinoma","volume":"14","author":"Wu","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.gene.2026.150438_b1205","doi-asserted-by":"crossref","first-page":"618","DOI":"10.7150\/ijms.69645","article-title":"Identification and validation of the N6-methyladenosine RNA methylation regulator ZC3H13 as a novel prognostic marker and potential target for hepatocellular carcinoma","volume":"19","author":"Wu","year":"2022","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.gene.2026.150438_b1210","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.18632\/aging.203939","article-title":"Downregulation of ZC3H13 by miR-362-3p\/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma","volume":"14","author":"Wu","year":"2022","journal-title":"Aging (Albany NY)"},{"issue":"653\u2013668","key":"10.1016\/j.gene.2026.150438_b1215","first-page":"e7","article-title":"CHD4 Has Oncogenic Functions in Initiating and Maintaining Epigenetic Suppression of Multiple Tumor Suppressor Genes","volume":"31","author":"Xia","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.gene.2026.150438_b1220","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11102909","article-title":"Circular RNAs Acting as miRNAs' Sponges and Their Roles in Stem Cells","volume":"11","author":"Xiao","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.gene.2026.150438_b1225","first-page":"528","article-title":"Loss of ARID1A Promotes Hepatocellular Carcinoma Progression via Up-regulation of MYC Transcription","volume":"9","author":"Xiao","year":"2021","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.gene.2026.150438_b1230","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.31557\/APJCP.2023.24.11.3851","article-title":"Association of APC Expression with Its Promoter Methylation Status and the Prognosis of Hepatocellular Carcinoma","volume":"24","author":"Xing","year":"2023","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.gene.2026.150438_b1235","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1158\/1055-9965.EPI-17-0770","article-title":"Serum Exosomal Long Noncoding RNAs ENSG00000258332.1 and LINC00635 for the Diagnosis and Prognosis of Hepatocellular Carcinoma","volume":"27","author":"Xu","year":"2018","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.gene.2026.150438_b1240","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/mc.23802","article-title":"m6A modification of VEGFA mRNA by RBM15\/YTHDF2\/IGF2BP3 contributes to angiogenesis of hepatocellular carcinoma","volume":"63","author":"Xu","year":"2024","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.gene.2026.150438_b1245","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109775","article-title":"The role of miR-155 on liver diseases by modulating immunity, inflammation and tumorigenesis","volume":"116","author":"Xue","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.gene.2026.150438_b1250","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1151069","article-title":"m(6)A reader proteins: the executive factors in modulating viral replication and host immune response","volume":"13","author":"Yang","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.gene.2026.150438_b1260","article-title":"Functional roles and mechanisms of circRNA-protein interactions in cancer progression and tumor immune regulation","volume":"17","author":"Yang","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.gene.2026.150438_b1265","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13148-025-02010-y","article-title":"Lysine demethylases 6 A and 6B as epigenetic regulators in therapeutic resistance of cancer","volume":"17","author":"Yang","year":"2025","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.gene.2026.150438_b1270","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13046-023-02659-4","article-title":"FGFR4 and EZH2 inhibitors synergistically induce hepatocellular carcinoma apoptosis via repressing YAP signaling","volume":"42","author":"Yang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.gene.2026.150438_b1275","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.tranon.2018.07.002","article-title":"CBX1 Indicates Poor Outcomes and Exerts Oncogenic Activity in Hepatocellular Carcinoma","volume":"11","author":"Yang","year":"2018","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.gene.2026.150438_b1280","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1074\/jbc.M116.749689","article-title":"MicroRNA-145 Modulates N(6)-Methyladenosine Levels by Targeting the 3'-Untranslated mRNA Region of the N(6)-Methyladenosine Binding YTH Domain Family 2 Protein","volume":"292","author":"Yang","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2026.150438_b1285","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00535-023-02053-z","article-title":"Three-dimensional chromatin landscapes in hepatocellular carcinoma associated with hepatitis B virus","volume":"59","author":"Yang","year":"2024","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.gene.2026.150438_b1255","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3350\/cmh.2019.0010","article-title":"Detect or not to detect very early stage hepatocellular carcinoma? The western perspective","volume":"25","author":"Yang, j. d.","year":"2019","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.gene.2026.150438_b1290","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1200\/JCO.2011.41.2395","volume":"30","author":"Yeo","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gene.2026.150438_b1295","doi-asserted-by":"crossref","first-page":"14452","DOI":"10.1038\/s41598-020-71324-z","article-title":"Novel miRNA signature for predicting the stage of hepatocellular carcinoma","volume":"10","author":"Yerukala sathipati, s. & ho, s. y.","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2026.150438_b1300","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.929787","article-title":"Diagnostic implication of a circulating serum-based three-microRNA signature in hepatocellular carcinoma","volume":"13","author":"Yousuf","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.gene.2026.150438_b1305","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/ijc.32647","article-title":"Plasma circular RNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma: A large-scale, multicenter study","volume":"146","author":"Yu","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.gene.2026.150438_b1310","doi-asserted-by":"crossref","DOI":"10.1186\/s43556-026-00427-2","article-title":"Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities","volume":"7","author":"Yu","year":"2026","journal-title":"Mol Biomed"},{"key":"10.1016\/j.gene.2026.150438_b1315","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.3748\/wjg.v20.i17.4953","article-title":"Inhibition of autophagy signi fi cantly enhances combination therapy with sorafenib and HDAC inhibitors for human hepatoma cells","volume":"20","author":"Yuan","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.gene.2026.150438_b1320","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41421-018-0019-0","article-title":"VIRMA mediates preferential m(6)A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation","volume":"4","author":"Yue","year":"2018","journal-title":"Cell Discov"},{"key":"10.1016\/j.gene.2026.150438_b1325","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10081715","article-title":"Host Epigenetic Alterations and Hepatitis B Virus-Associated Hepatocellular Carcinoma","volume":"10","author":"Zeisel","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.gene.2026.150438_b1330","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4161\/epi.5.4.11683","article-title":"HP1: heterochromatin binding proteins working the genome","volume":"5","author":"Zeng","year":"2010","journal-title":"Epigenetics"},{"key":"10.1016\/j.gene.2026.150438_b1335","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bbrc.2020.09.050","article-title":"Knockdown of circ_HIPK3 inhibits tumorigenesis of hepatocellular carcinoma via the miR-582-3p\/DLX2 axis","volume":"533","author":"Zhang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.gene.2026.150438_b1340","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/s41419-022-05386-4","article-title":"ALKBH5-mediated m(6)A modification of lincRNA LINC02551 enhances the stability of DDX24 to promote hepatocellular carcinoma growth and metastasis","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150438_b1345","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1038\/s41598-025-89614-9","article-title":"BRD4 interacting genes as prognostic biomarkers in hepatocellular carcinoma for optimized treatment strategies","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2026.150438_b1350","article-title":"Sorafenib inhibits epithelial-mesenchymal transition through an epigenetic-based mechanism in human lung epithelial cells","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2026.150438_b1355","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41419-018-0344-0","article-title":"PU.1\/microRNA-142-3p targets ATG5\/ATG16L1 to inactivate autophagy and sensitize hepatocellular carcinoma cells to sorafenib","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150438_b1360","first-page":"385","article-title":"FTO Promotes Hepatocellular Carcinoma Progression by Mediating m6A Modification of BUB1 and Targeting TGF-betaR1 to Activate the TGF-beta Signaling Pathway","volume":"13","author":"Zhang","year":"2025","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.gene.2026.150438_b1365","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215899","article-title":"DNMT and EZH2 inhibitors synergize to activate therapeutic targets in hepatocellular carcinoma","volume":"548","author":"Zhang","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.gene.2026.150438_b1370","article-title":"CircRNA-miRNA-VEGFA: an important pathway to regulate cancer pathogenesis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.gene.2026.150438_b1375","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13148-025-01925-w","article-title":"Decitabine regulates the resistance of HCC to sorafenib through demethylation","volume":"17","author":"Zhang","year":"2025","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.gene.2026.150438_b1380","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1515\/oncologie-2025-0419","article-title":"A comprehensive review of histone deacetylases: implications for pathogenesis and targeted therapy in hepatocellular carcinoma","volume":"28","author":"Zhang","year":"2026","journal-title":"Oncologie"},{"key":"10.1016\/j.gene.2026.150438_b1385","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/s41419-018-1132-6","article-title":"circRNA_104075 stimulates YAP-dependent tumorigenesis through the regulation of HNF4a and may serve as a diagnostic marker in hepatocellular carcinoma","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150438_b1390","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3892\/ijo.2017.4164","article-title":"Long non\u2011coding RNA HOTTIP promotes hepatocellular carcinoma tumorigenesis and development: A comprehensive investigation based on bioinformatics, qRT\u2011PCR and meta\u2011analysis of 393 cases","volume":"51","author":"Zhang","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.gene.2026.150438_b1395","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.trecan.2023.07.017","article-title":"Spatial promoter-enhancer hubs in cancer: organization, regulation, and function","volume":"9","author":"Zhao","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.gene.2026.150438_b1400","doi-asserted-by":"crossref","first-page":"196","DOI":"10.18632\/oncoscience.420","article-title":"The therapeutic properties of resminostat for hepatocellular carcinoma","volume":"5","author":"Zhao","year":"2018","journal-title":"Oncoscience"},{"key":"10.1016\/j.gene.2026.150438_b1405","article-title":"Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC)","volume":"11","author":"Zhao","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.gene.2026.150438_b1410","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3233\/CBM-170791","article-title":"Overexpression of YTHDF1 is associated with poor prognosis in patients with hepatocellular carcinoma","volume":"21","author":"Zhao","year":"2018","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.gene.2026.150438_b1415","doi-asserted-by":"crossref","first-page":"90","DOI":"10.21037\/tcr-2025-1417","article-title":"Identification of immune-related targets of N6-methyladenosine regulators in hepatocellular carcinoma via RNA-seq analysis","volume":"15","author":"Zhao","year":"2026","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.gene.2026.150438_b1420","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12935-025-03923-7","article-title":"Targeting m6A methylation for early diagnosis and precision medicine in hepatocellular carcinoma","volume":"25","author":"Zheng","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.gene.2026.150438_b1425","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1038\/srep04147","article-title":"Genetic variant in SWI\/SNF complexes influences hepatocellular carcinoma risk: a new clue for the contribution of chromatin remodeling in carcinogenesis","volume":"4","author":"Zhong","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2026.150438_b1430","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s13046-022-02538-4","article-title":"A functional loop between YTH domain family protein YTHDF3 mediated m(6)A modification and phosphofructokinase PFKL in glycolysis of hepatocellular carcinoma","volume":"41","author":"Zhou","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.gene.2026.150438_b1435","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e38562","article-title":"Relationship between EZH2 expression and prognosis of patients with hepatocellular carcinoma using a pathomics predictive model","volume":"10","author":"Zhou","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.gene.2026.150438_b1440","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.80854","article-title":"MLL3 regulates the CDKN2A tumor suppressor locus in liver cancer","volume":"12","author":"Zhu","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.gene.2026.150438_b1445","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/carcin\/bgv112","article-title":"MiR-17-92 cluster promotes hepatocarcinogenesis","volume":"36","author":"Zhu","year":"2015","journal-title":"Carcinogenesis"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926004488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926004488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T17:24:32Z","timestamp":1792949072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111926004488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":289,"alternative-id":["S0378111926004488"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2026.150438","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The epigenetic landscape of hepatocellular carcinoma: from molecular mechanisms to early detection biomarkers and precision therapy","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2026.150438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150438"}}